Determination of phospholipase D, lysophospholipase D and DG kinase signaling pathways in disease states by mass spectrometry.
Wakelam
Michael J O
MJ
The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom. michael.wakelam@bbsrc.ac.uk
Powner
Dale J
DJ
Pettitt
Trevor R
TR
D000818:Animals; D002464:Cell Migration Inhibition / Q000187:drug effects; D019852:Diacylglycerol Kinase / Q000502:physiology*; D006801:Humans; D013058:Mass Spectrometry; D009097:Multienzyme Complexes / Q000502:physiology; D009504:Neutrophils / Q000502:physiology; D010712:Phosphatidic Acids / Q000502:physiology*; D043264:Phosphodiesterase I / Q000502:physiology; D010739:Phospholipase D / Q000502:physiology*; D010727:Phosphoric Diester Hydrolases / Q000502:physiology*; D011755:Pyrophosphatases / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*; D000099189:Lysophospholipase D
D019852:Diacylglycerol Kinase; D009097:Multienzyme Complexes; D010712:Phosphatidic Acids; D043264:Phosphodiesterase I; D010739:Phospholipase D; D010727:Phosphoric Diester Hydrolases; D011755:Pyrophosphatases; D000099189:Lysophospholipase D